Małgorzta Pyda

Prof. Dr. Małgorzta Pyda

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
AKAnna Kociemba
Anna Kociemba
MPMałgorzta Pyda
Małgorzta Pyda
KKKatarzyna Katulska
Katarzyna Katulska
MŁMagdalena Łanocha
Magdalena Łanocha
ASAndrzej Siniawski
Andrzej Siniawski
Stefan GrajekStefan Grajek
Stefan Grajek
Recent studies, performed with the use of a commercially available diffusion weighted imaging (DWI) sequence, showed that they are sensitive to the increase of water content in the myocardium and may be used as an alternative to the standard T2-weighted sequences. The aim of this study was to compare two methods of myocardial edema imaging: DWI and T2-TIRM.

1 December 2019 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
ACAleksandra Cieplucha
Aleksandra Cieplucha
OTOlga Trojnarska
Olga Trojnarska
ABAgnieszka Bartczak-Rutkowska
Agnieszka Bartczak-Rutkowska
AKAnna Kociemba
Anna Kociemba
JRJustyna Rajewska-Tabor
Justyna Rajewska-Tabor
MPMałgorzta Pyda
Małgorzta Pyda

30 March 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
KMKatarzyna Małaczyńska-Rajpold
Katarzyna Małaczyńska-Rajpold
KBKrzysztof Błaszyk
Krzysztof Błaszyk
AKAnna Kociemba
Anna Kociemba
MPMałgorzta Pyda
Małgorzta Pyda
APAnna Posadzy‐Malaczynska
Anna Posadzy‐Malaczynska
Stefan GrajekStefan Grajek
Stefan Grajek

Verified
Journal Article
Open access
PDF file
Marta Kaluzna-OleksyMarta Kaluzna-Oleksy
Marta Kaluzna-Oleksy
WSWOJCIECH JAN SKORUPSKI
WOJCIECH JAN SKORUPSKI
MGMarek Grygier
Marek Grygier
Aleksander AraszkiewiczAleksander Araszkiewicz
Aleksander Araszkiewicz
WSWłodzimierz Skorupski
Włodzimierz Skorupski
MLMaciej Lesiak
Maciej Lesiak
There is still controversy whether the female gender is associated with worse outcomes after the percutaneous coronary intervention within the left main (LM PCI). This study aimed to examine gender-based differences in real-life LM PCI patients and present a gender-personalized LM PCI approach. Consecutively, 613 patients underwent LM PCI in our department from January 2015 to June 2019. Five hundred and thirty-three patients, with at least a one-year follow-up, were included in the study. There were 130 (24.4%) women and 403 (75.6%) men. Compared with men, women were older (70.0 ± 9.4 vs. 67.7 ± 9.2; p = 0.006) and had higher diabetes, hypertension, and chronic kidney disease rates. Left ventricle ejection fraction was higher in women (53.5 ± 9.4 vs. 49.5 ± 11.2; p = 0.001). Euroscore II and SYNTAX scores did not differ between the genders. However, we observed a trend towards more frequent use of complex PCI techniques in women (26.2% vs. 19.4%; p = 0.098). The overall periprocedural complication rates (10.0% vs. 7.7%; p = 0.406) and the periprocedural myocardial infarction rates did not differ. Contrast-induced nephropathy was more frequent in women (6.9% vs. 3.0%; p = 0.044). Long-term all-cause mortality did not differ (20% vs. 22.5%; p = 0.069). Both genders presented similar rates of periprocedural complications, and no significant differences in long-term all-cause mortality were revealed. Our results suggest that the female gender in LM PCI is not a predictor of adverse outcomes. Further studies are required to determine the optimal revascularization strategy in women.

4 December 2014 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
DKDominika Kanikowska
Dominika Kanikowska
MPMałgorzta Pyda
Małgorzta Pyda
KKKatarzyna Korybalska
Katarzyna Korybalska
SGStefan Grajek
Stefan Grajek
MLMaciej Lesiak
Maciej Lesiak
JWJanusz Witowski
Janusz Witowski
Interleukin-6 (IL-6) is an inflammatory cytokine whose levels increase significantly during myocardial infarction (MI). It has been hypothesised that the concentrations of IL-6 at admission may be useful in prognosticating long-term outcomes. It is unclear, however, whether IL-6 could improve the prognosis of early mortality in MI. We have compared serum IL-6 levels and analysed the disease course in 158 patients with ST-elevation MI (STEMI) who either survived (n = 148) or died (n = 10) within 30 days following the admission. Patients were treated in a single university centre with primary percutaneous coronary intervention (PCI). The non-survivors (6.3%) displayed most of typical risk factors for poor outcome. In addition they had significantly higher concentrations of IL-6 at hospital admission (median values 8.5 vs. 2.0 pg/ml; p = 0.038). However, they were also significantly older than the survivors (median values 72 vs. 57 years; p = 0.0001). IL-6 levels are known to increase with age and we could confirm a significant correlation between patients’ calendar age and circulating IL-6 (p = 0.009). Regression analysis revealed that IL-6 concentrations were significantly affected by patients’ age but they did not independently relate to patients’ outcome. Such results indicate that circulating IL-6 at admission may be of limited value in predicting early mortality in STEMI. It is important to recognize that, because of the small group of patients who died (N = 10), the results must be interpreted with caution. Therefore, we stress that these results should be viewed as preliminary and further validated in a larger set of patients.

7 February 2010 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
KKKatarzyna Korybalska
Katarzyna Korybalska
MPMałgorzta Pyda
Małgorzta Pyda
Stefan GrajekStefan Grajek
Stefan Grajek
MŁMagdalena Łanocha
Magdalena Łanocha
ABAndrzej Brȩborowicz
Andrzej Brȩborowicz
JWJanusz Witowski
Janusz Witowski